CS138492A3 - Amino acid derivative, process for preparing thereof and a pharmaceuticalcomposition containing said derivative - Google Patents

Amino acid derivative, process for preparing thereof and a pharmaceuticalcomposition containing said derivative

Info

Publication number
CS138492A3
CS138492A3 CS921384A CS138492A CS138492A3 CS 138492 A3 CS138492 A3 CS 138492A3 CS 921384 A CS921384 A CS 921384A CS 138492 A CS138492 A CS 138492A CS 138492 A3 CS138492 A3 CS 138492A3
Authority
CS
Czechoslovakia
Prior art keywords
formula
derivative
alkyl
alkoxycarbonyl
aralkanoyl
Prior art date
Application number
CS921384A
Other languages
English (en)
Inventor
Joseph Armstrong Martin
Gareth John Thomas
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919110170A external-priority patent/GB9110170D0/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CS138492A3 publication Critical patent/CS138492A3/cs
Publication of CZ281839B6 publication Critical patent/CZ281839B6/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/24Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
    • C07C255/29Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton containing cyano groups and acylated amino groups bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cleaning Or Clearing Of The Surface Of Open Water (AREA)
  • Measurement Of Force In General (AREA)
  • Confectionery (AREA)
  • Enzymes And Modification Thereof (AREA)
CS921384A 1991-05-10 1992-05-07 Derivát aminokyseliny, způsob jeho přípravy a farmaceutický prostředek, který ho obsahuje CZ281839B6 (cs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919110170A GB9110170D0 (en) 1991-05-10 1991-05-10 Amino acid derivatives
GB929203014A GB9203014D0 (en) 1991-05-10 1992-02-13 Amino acid derivatives

Publications (2)

Publication Number Publication Date
CS138492A3 true CS138492A3 (en) 1992-11-18
CZ281839B6 CZ281839B6 (cs) 1997-02-12

Family

ID=26298885

Country Status (24)

Country Link
US (2) US5430041A (cs)
EP (1) EP0512343B1 (cs)
JP (1) JPH06102639B2 (cs)
AT (1) ATE125792T1 (cs)
AU (1) AU660308B2 (cs)
CA (1) CA2067690C (cs)
CZ (1) CZ281839B6 (cs)
DE (1) DE69203780T2 (cs)
DK (1) DK0512343T3 (cs)
DZ (1) DZ1578A1 (cs)
ES (1) ES2075976T3 (cs)
FI (2) FI110938B (cs)
GR (1) GR3017902T3 (cs)
HR (1) HRP931025B1 (cs)
HU (1) HU210283B (cs)
IE (1) IE69169B1 (cs)
IL (3) IL101770A (cs)
IS (1) IS1747B (cs)
MX (1) MX9202146A (cs)
MY (1) MY108770A (cs)
NO (1) NO300496B1 (cs)
NZ (1) NZ242593A (cs)
RO (1) RO109540B1 (cs)
SK (1) SK281183B6 (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5413999A (en) * 1991-11-08 1995-05-09 Merck & Co., Inc. HIV protease inhibitors useful for the treatment of AIDS
US5679688A (en) * 1992-03-11 1997-10-21 Narhex Limited Quinaldoyl-amine derivatives of oxo-and hydroxy-substituted hydrocarbons
US6071895A (en) * 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
DE69333270T2 (de) 1992-03-11 2004-08-05 Narhex Ltd. Aminderivate von oxo- und hydroxy- substituierten kohlenwasserstoffen
US5733906A (en) * 1993-10-12 1998-03-31 Eli Lilly And Company Inhibitors of HIV Protease useful for the treatment of Aids
MX9308016A (es) * 1992-12-22 1994-08-31 Lilly Co Eli Compuestos inhibidores de la proteasa del virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulacion farmaceutica que los contiene.
US5491166A (en) * 1992-12-22 1996-02-13 Eli Lilly And Company Inhibitors of HIV protease useful for the treatment of AIDS
US5591885A (en) * 1994-09-23 1997-01-07 Hoffman-La Roche Inc. Process for the preparation of halogenated α-aminoketone compounds
US5523463A (en) * 1994-09-23 1996-06-04 Hoffmann-La Roche Inc. Method of producing halogenated and alpha-aminoalchohols
GB0123467D0 (en) 2001-09-28 2001-11-21 Hoffmann La Roche Carbocyclic HIV Protease inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE447633B (sv) * 1978-09-19 1986-12-01 Albany Int Corp Forfarande for separering och modul for genomforande av forfarandet
JPS63166826A (ja) * 1986-12-27 1988-07-11 Shin Etsu Chem Co Ltd 抗ヒトレトロウイルス剤
CA1340588C (en) * 1988-06-13 1999-06-08 Balraj Krishan Handa Amino acid derivatives
CA2010531A1 (en) * 1989-03-06 1990-09-06 Werner Neidhart Amino acid derivatives
CA2012901A1 (en) * 1989-04-05 1990-10-05 Quirico Branca Amino acid derivatives
GB8927913D0 (en) * 1989-12-11 1990-02-14 Hoffmann La Roche Amino acid derivatives
CN1071930A (zh) * 1991-07-10 1993-05-12 伊莱利利公司 用作治疗艾滋病的人免疫缺陷病毒蛋白酶的抑制剂

Also Published As

Publication number Publication date
FI922094A0 (fi) 1992-05-08
NO921828D0 (no) 1992-05-08
US5430041A (en) 1995-07-04
EP0512343A3 (en) 1993-03-24
HRP931025A2 (en) 1996-06-30
AU1600792A (en) 1992-11-12
MX9202146A (es) 1992-11-01
IL101770A0 (en) 1992-12-30
IL112900A (en) 1997-06-10
IE69169B1 (en) 1996-08-07
JPH05155834A (ja) 1993-06-22
FI990399A7 (fi) 1999-02-24
FI990399A0 (fi) 1999-02-24
CA2067690C (en) 2005-09-06
RO109540B1 (ro) 1995-03-30
MY108770A (en) 1996-11-30
IE921490A1 (en) 1992-11-18
CA2067690A1 (en) 1992-11-11
DE69203780T2 (de) 1995-12-07
IL101770A (en) 1996-06-18
NO921828L (no) 1992-11-11
DK0512343T3 (da) 1995-10-16
EP0512343A2 (en) 1992-11-11
HU9201514D0 (en) 1992-07-28
HU210283B (en) 1995-03-28
AU660308B2 (en) 1995-06-22
JPH06102639B2 (ja) 1994-12-14
NZ242593A (en) 1994-06-27
DZ1578A1 (fr) 2002-02-17
HRP931025B1 (en) 2000-06-30
GR3017902T3 (en) 1996-01-31
IL112900A0 (en) 1995-06-29
HUT61972A (en) 1993-03-29
CZ281839B6 (cs) 1997-02-12
IS1747B (is) 2000-07-11
NO300496B1 (no) 1997-06-09
SK281183B6 (sk) 2001-01-18
US5583248A (en) 1996-12-10
DE69203780D1 (de) 1995-09-07
FI110938B (fi) 2003-04-30
EP0512343B1 (en) 1995-08-02
ATE125792T1 (de) 1995-08-15
IS3858A (is) 1992-11-11
FI922094A7 (fi) 1992-11-11
ES2075976T3 (es) 1995-10-16

Similar Documents

Publication Publication Date Title
IE891879L (en) Amino Acid Derivatives
CS138492A3 (en) Amino acid derivative, process for preparing thereof and a pharmaceuticalcomposition containing said derivative
GB2163156B (en) Carbapenem derivatives, their preparation and compositions containing them
IL100502A0 (en) Pharmaceutical compositions containing 1,3-oxathiolane nucleoside analogues
HUT70426A (en) Pyrazolo-pyrimidine derivatives, process for preparing them and pharmaceutical compositions containing them as active agents
PH25859A (en) Composition for treatment of ischemic disorder
SG49692A1 (en) Process for the production of a pharmaceutical agent for oral or topical administration in the treatment of leishmaniasis
AU8155494A (en) Methods of increasing thrombomodulin expression
HU9201033D0 (en) Tiazolidinone- and oxazolidinone derivatives, process for their production, and for the production of medical preparations containing them as active agents
AU1166988A (en) New peptide derivatives having a polycyclic nitrogenous structure, process for the preparation thereof and pharmaceutical compositions containing them
DE69837331D1 (en) Trizyklische keto amid derivative als farnesyl protein transferase inhibitoren
TW282470B (cs)
YU49092A (sh) Derivati aminokiselina
HUT47535A (en) Process for producing ethanonoxime derivatives and pharmaceuticals comprising such active ingredient
KR940005279A (ko) 아미딘을 함유하는 약제학적 조성물 및 아미딘

Legal Events

Date Code Title Description
IF00 In force as of 2000-06-30 in czech republic
MM4A Patent lapsed due to non-payment of fee

Effective date: 20020507